Chen Franco-Yehuda - 11 Sep 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Reporting relationship: Chief Financial Officer
Issuer ticker: DRIO
Reported as of: 11 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Sep 2025, 16:07:27 UTC
Prior SEC filing: 15 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Chen Franco-Yehuda

Key filing fact

Chen Franco-Yehuda filed Form 4 for DarioHealth Corp. (DRIO) on 15 Sep 2025.

Key facts

This page summarizes Chen Franco-Yehuda's Form 4 filing for DarioHealth Corp. (DRIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2025, 16:07.

Change

Previous filing in this sequence was filed on 15 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001770681 Primary reporting owner

Franco-Yehuda Chen

Relationship: Chief Financial Officer
Address: 322 W 57TH STREET, #33B, NEW YORK
Signature: /s/ Chen Franco-Yehuda
Signature date: 15 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRIO transaction

Common Stock

Award

Transaction value: $0
Shares: +5,000
Change %: +20%
Price: $0.000000
Shares after: 30,000
Date: 11 Sep 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

Footnote F2

The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.